*typically outpatient
*can be outpatient
2. Drug name, dose, quantity, form, strength
3. Directions for use (sig)
4. Refills authorization (if any)
5. Date of issue
6. Name & address of prescriber
7. Prescriber's signature, if written
8. DEA registration number of the prescriber
2. Dispensing pharmacists's identification
3. Date of dispensing
4. Retrieval designation (serial #)
5. Brand name vs. generic dispensed
6. Record of all refills
7. Controlled substances
2. Brand name or manufacturer and strength or concentration of manufacturer drug products used as ingredients
3. Capsule size and color (physical descriptions of the medication dispensed)
4. Compounding aids (vehicles, solvents, flavors, buffers, etc)
5. Accurate account of the amount of a controlled drug weighed, dispensed, and discarded
6. Calculations, quantities of ingredients weighed or measured
2. Pharmacy address
3. Name of patient
4. Name of prescriber
5. Directions for use as stated on the Rx
6. Date dispensed
7. Cautionary statements, if any
8. Serial number of prescription
9. Name or initials of the dispensing pharmacist
10. Name and strength of drug dispensed
11. Name of the manufacturer
(Some states require additional information like quantity dispensed, Expiration date or beyond use labeling and number of refills
*only experimentally controlled in research
*inventory must be taken every other year (count every last pill)
*a prescription must be clearly written with no markings
*faxed Rx are permitted in emergency situations provided the pharmacist is given the original signed prescription order for review prior to the actual dispensing of the controlled drug
-Schedule III, IV, and V prescriptions in a SEPARATE file
-Non-controlled prescriptions in a SEPARATE file
-Schedule III, IV, and V prescriptions marked with one-inch-high red "C" stamp and filed with non-controlled prescriptions
-Non-controlled prescriptions in a SEPARATE file
2. Pharmacy name and address
3. Rx ID or serial number
4. Name of patient
5. Name of prescriber
6. Direction for use and any cautionary statements
7. A federal transfer label (except for 5)
shall not be later than (a) the expiration date on the original container (b) one year from the date the drug is dispensed.
* for multi-dose containers
a. Use manufacturer's expiration date or 1 year from dispensing time, whichever is earlier.
b. Shorter time for transferred products from its original container.
c. The RPH should be conscious of recommended storage conditions for a drug product.
*for compounded products done by the dispensing pharmacist
a. Take into consideration the expiration dates
of all the ingredients used in the compound.
b. Six (6) factors affecting expiration date assigned to any of the single original ingredients.
c. Six (6) month-25% rule
1. nature of each ingredient
2. how the combination of ingredients affect stability
3. dry products are more stable than any aqueous solution
4. compounding procedures must be recorded
5. packaging used for preparation (ex: moisture & heat)
6. Storage conditions (ex: humidity, dry, heat, etc..)
The remaining time between the date of the compounding and the shortest expiration date of the ingredient (whichever is greater)
if a drug product has a 6 month expiration date we can use that OR take 25% of the original date
Six (6) month - 25% rule
oral products
*More stable products = 1 month
*less stable products = 7-14 days
topical products
*more stable products = 2-6 months
*less stable = shorter time
Solutions and suspensions
preserved = 1-2 weeks
unpreserved = STAT use and discard
Ophthalmic solutions
internal = 14 days
external = 30 days
use 6 months or 25% rule
parenteral products expiration
25% of the remaining time between the date of repackaging and the expiration date on the original manufacturer container/bulk container OR 6 month period from the date the drug is repackaged (whichever is earlier)
*this assumes the product is stored at room temp, relative humidity not exceeding 75% at 23 Celsius
60 days from the preparation time